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Background:Religiously motivated Bahá’í fasting (BF) is a form of intermittent dry fasting
celebrated by abstaining from food and drinks during daylight hours every year in March
for 19 consecutive days.
Aim: To test the safety and effects of BF on hydration, metabolism, and the
circadian clock.
Methods: Thirty-four healthy Bahá’í volunteers (15 women) participated in this
prospective, exploratory cohort study. Laboratory examinations were carried out in four
study visits: before fasting (V0), in the third week of fasting (V1) as well as 3 weeks
(V3) and 3 months (V4) after fasting. Data collection included blood and urine samples,
anthropometric measurements and bioelectrical impedance analysis. At V0 and V1, 24-
and 12-hour urine and serum osmolality were measured. At V0–V2, alterations in the
circadian clock phase were monitored in 16 participants. Our study was augmented by
an additional survey with 144 healthy Bahá’í volunteers filling out questionnaires and with
subgroups attending metabolic measurements (n = 11) and qualitative interviews (n =
13), the results of which will be published separately.
Results: Exploratory data analysis revealed that serum osmolality (n = 34, p < 0.001)
and 24-hour urine osmolality (n = 34, p = 0.003) decreased during daytime fasting but
remained largely within the physiological range and returned to pre-fasting levels during
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night hours. BMI (body mass index), total body fat mass, and resting metabolic rate
decreased during fasting (n = 34, p < 0.001), while body cell mass and body water
appeared unchanged. The circadian phase estimated by transcript biomarkers of blood
monocytes advanced by 1.1 h (n = 16, p < 0.005) during fasting and returned to
pre-fasting values 3 weeks after fasting. Most observed changes were not detectable
anymore 3 months after fasting.
Conclusions: Results indicate that BF (Bahá’í fasting) is safe, has no negative effects
on hydration, can improve fat metabolism and can cause transient phase shifts of
circadian rhythms.
Trial Registration: https://www.clinicaltrials.gov/, identifier: NCT03443739.
Keywords: hydration, religious, intermittent fasting, chronobiology, water deprivation, time-restricted eating,
fasting, diurnal fasting
INTRODUCTION
Fasting with its preventive and therapeutic effects has, in general,
been explored more and more over the past decade (1–10).
However, dry fasting (DF) has not received as much attention
in the scientific community. Most studies in this regard have
focused on the Ramadan fast (11, 12), not specifically exploring
DF as such, while serious consequences of a dysregulated body
fluid balance are clear for every clinician (13), making studies on
DF difficult to conduct.
However, Ramadan fasting is a complex model for DF, as
the daily duration of fasting varies greatly over the years (from
11 to 22 hours a day, depending on the season and geographic
location) (14). Apart from studies on Ramadan fasting, only a
few studies have focused on DF itself (15–20). From these, only
Papagiannopoulos et al. and Papagiannopoulos-Vatopaidinos et
al. (15, 20) have focused on the physiology of prolonged DF,
examining 10 participants each for 5 consecutive days of water
and food deprivation.
The Bahá’í religion is monotheistic and was founded by
Bahá’u’lláh (1817–1892) (21). Fasting is seen by Bahá’ís as one of
the most significant spiritual duties of a healthy individual (22).
The sick, the elderly, as well as children under 15 years of age and
pregnant, menstruating, or nursing women are exempt from the
religious duty to fast (22). Worldwide, the followers of the Bahá’í
religion fast every year in March, abstaining from food and drink
from sunrise to sunset for 19 consecutive days (22). This practice
could best be described as an intermittent dry fast. No additional
dietary regulations exist for believers during the fasting period
or in general, except that consumption of alcoholic beverages is
Abbreviations: BIA, bioelectrical impedance analysis; BGA, blood gas analysis;
BMI, body mass index; BF, Bahá’í fasting; BQ, participants of the large-scale
study with questionnaires; CB, participants of chronobiological measurements;
DC, Department of Chronobiology; DF, dry fasting; DLMO, dim light melatonin
onset; ECRC, experimental and clinical research center; HbA1c, glycosylated
hemoglobin; IDF, intermittent dry fasting; IM, Department of IntegrativeMedicine
under the Institute of Social Medicine, Epidemiology and Health Economics; PP,
participants of laboratory and anthropometric measurements; V0, V1, V2, and V3,
study visits with laboratory examinations; VQ1, VQ2, VQ3, and VQ4, study visits
with questionnaires.
prohibited throughout the year. In contrast to Ramadan fasting,
Bahá’í fasting (BF) has a fixed date in the year, is of shorter
duration (i.e. 19 days) and, since it takes place in March, fasting
time varies only between 10–13 hours daily. At the study site
in Berlin/Germany, the exact duration is 10.90 hours at the
beginning and 12.12 hours at the end of the fasting period. This
makes it a good model for exploring the effects of intermittent
dry fasting (IDF) on healthy adults, as no relevant changes occur
in climate or timing when comparing data from different years or
places. Since research has suggested that Ramadan fasting causes
alterations of normal circadian rhythms (23), we also explored
the effects of BF on the circadian phase (chronotype).
Thus, in this exploratory study, fluid balance in healthy adults
during a religiously motivated IDF was assessed. Additionally,
it was explored, whether known physiological mechanisms of
fasting are also activated through this kind of fasting, which is
shorter in duration than other fasting intervals of, for example,
time-restricted eating (1) or intermittent fasting (5). More
specifically, the aim was to assess urine and serum osmolality,
renal and liver function, blood fatty acids, ketones, blood gas
analysis, and anthropometric variables, as well as effects on
normal daily patterns of eating and drinking. The collected data
should serve to generate hypotheses for future studies in the field
of IDF in general as well as assessing the safety and effects of BF.
METHODS
Study Design
This longitudinal, exploratory cohort study focussed on changes
in physiological parameters. It was augmented by a mixed-
methods study on Bahá’í fasting.
This study represents a quasi-experiment with a longitudinal
observational design (24). As fasting time and duration are fixed
for all Bahá’ís by religious provisions, there was no possibility
to randomize the volunteers into a fasting and a non- (or
delayed-) fasting group. Using a control group with a non-
religious motivation could lead to a bias, as religiously motivated
people may have higher compliance rates to dietary norms as
well as engage in different health-related behaviors compared
Frontiers in Nutrition | www.frontiersin.org 2 July 2021 | Volume 8 | Article 662310
Koppold-Liebscher et al. A Prospective Cohort Study on Bahá’í Fasting
FIGURE 1 | A flow chart of visits with participant numbers.
with non-adherents (25). The external laboratory personnel, as
well as the statistician, were blinded. All other study personnel
were involved directly with the study participants during visits.
Therefore, no blinding was possible in this case.
The study protocol was approved by the institutional review
board of Charité Universitätsmedizin Berlin (Charitéplatz 1,
10117 Berlin) in January 2018 (ID: EA4/216/17), was registered
with ClinicalTrials.gov (ID: NCT03443739), and carried out
according to the standards of the Declaration of Helsinki.
Written informed consent was obtained from all the participants
prior to study entry.
Setting
Three departments of the same university (Charité
Universitätsmedizin Berlin) cooperated for this study: the
Department of Integrative Medicine at the Institute of Social
Medicine, Epidemiology and Health Economics (IM), the
Experimental and Clinical Research Center (ECRC), and
the Department of Chronobiology (DC). The two latter
departments conducted sub-studies. The main study site was
at the Department of Integrative Medicine. Physiological data
comprising urine and blood samples, as well as anthropometric
measurements, were acquired at the four in-house visits in the
Department of Integrative Medicine at the Institute of Social
Medicine, Epidemiology and Health Economics (IM) or, for a
subgroup, at the Experimental and Clinical Research Center
(ECRC). The visits were conducted in the 2 weeks before the
beginning of the fasting period (V0), in the last week of the
fast (V1), 3 weeks after the end of the fast (V2), and finally,
3 months after the end of the fasting period (V3). Figure 1
shows these visits along with the additional other visits for the
psychometric questionnaires of the companion study and the
other sub-studies.
Participants
Original first recruitment was conducted via the National
Spiritual Assembly of the Bahá’ís of Germany (23), who spread
the information via email to all Bahá’ís in Germany. For the
aims of this study, 172 healthy volunteers were screened, and
144 were considered eligible (see below) for the questionnaire
survey and were enclosed between January and February 2018.
All eligible individuals filled out electronic questionnaires on
subjective physical and psychological effects of Bahá’í fasting
(group “BQ”).
Of these, all the participants living in the wider region of
Berlin were invited to participate in the additional laboratory
tests reported upon here. Thirty-four subjects could be enclosed
in this sub-study with its tests for physiological parameters
(group “PP”), giving their informed written consent. Again, 17 of
these 34 participants agreed to donate additional blood samples
for chronobiological measurements and to answer additional
questionnaires (group “CB”). The results of the psychometric
questionnaires, as well as those of individual in-depth and
focus group interviews and another subgroup concentrating on
metabolic responses, will be reported separately.
Eligibility Criteria
The participants were screened at the IM and then referred to
all sub-studies.
Inclusion criteria were registered membership in the Bahá’í
community, planned adherence to fasting in the upcoming
fasting period and age between 18 and 69 years (children and
elderly are exempt from the religious duty to fast, and, because
of the necessity for informed consent, no youth between 15 and
17 years were recruited for the study).
Exclusion criteria were: scheduled interruption of the fast for
more than 5 days (for e.g., due to planned travel), pregnancy or
breastfeeding, serious physical, or psychological illness, known
eating disorder, participation in another study, no email address
(because of electronic questionnaires). Individuals who worked
in shifts and planned long-distance travel shortly before and
during the study period were also excluded from eligibility for
the chronobiological measurements.
Outcomes/Variables
Primary outcome measures were the hydration status of fasting
individuals and changes in serum osmolality and urine osmolality
in 12- and 24-hour-urine samples. Secondary outcome measures
were anthropometric parameters, such as body weight, BMI,
body composition via bioelectrical impedance analysis (BIA,
measured by the octapolar BIACORPUS RX 4004M R©) and the
waist-to-hip ratio. The resting metabolic rate was calculated by
an algorithm implemented in the BIA software provided by the
manufacturer. Blood pressure, heart rate, and standard blood
count were assessed alongside metabolic parameters, such as
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ketone bodies in capillary blood (on the spot, with ACCU-
CHEK R© device) and urine, blood glucose levels, glycosylated
hemoglobin (HbA1c), fructosamine, C-reactive protein, liver
enzymes, and serum cholesterol. Additionally, the fluid balance
was assessed by kidney parameters, 12- and 24-hour urine
creatinine clearance, serum electrolytes, acid-based balance
measured by blood gas analysis (on the spot, with the ABL80
FLEX R© blood gas analyser), 24-hour and spontaneous urine
osmolality, 24-hour urine specific gravity, and cystatin C. All
laboratory parameters were measured at Labor Berlin, unless
otherwise indicated. As most laboratory measurements had to
be carried out in a fasting state, they were carried out between
7:30 a.m. and 11:00 a.m. outside of the fasting period, while,
during BF, as most subjects would have breakfast before sunrise,
the measurements were done between 4:30 p.m. and 6:30 p.m., if
not otherwise indicated.
In group CB (17 subjects), an additional blood sample was
taken between ∼8 a.m. and ∼10 a.m. at V0, V1, and V2 to assess
the circadian phase (chronotype) (Supplementary Table 1) (26).
Note that the determination of the circadian phase with
the BodyTime assay is independent of the time of sample
collection (26). Briefly, monocytes were sorted fromwhole blood,
using magnetic cell sorting, total RNA was prepared, and the
expression of 24 biomarker genes was analyzed, usingNanoString
technology. Based on these data, the body time algorithm allowed
the prediction of the circadian phase. In this subgroup, the
validated Munich Chronotype questionnaire (27) was also used.
Timing of the measurements constituted a challenge. Due to
capacity constraints of the study centers, measurements could not
all be done at the same time. Therefore, the measurements had
to be spread over the last week of BF and start 2 hours before
breaking the fast for dinner so that the mean fasting time for
our measurements was 17 fasting days and 11 hours of daily
fasting duration.
For a better overview of the whole study setting, we also
mention the following measurements, the results of which will
be published separately: Body composition was measured by air-
displacement plethysmography, parameters of systemic energy
metabolism by indirect calorimetry, and parameters of adipose
tissue and skeletal muscle metabolism by microdialysis in two
subgroups. Furthermore, validated questionnaires on quality of
life, mood, mindfulness, and spirituality were used in electronic
form for the BQ group. Additionally, the focus group and
individual interviews were carried out by a trained sociologist.
Bias
Recruitment for both this study and the accompanying ones was
based on voluntary participation and may thus have introduced
a sampling bias in favor of motivated and health-conscious
subjects. Apart from that, the implementation of an intervention-
group-only design is, in so far, justified as the aim of the study
was to explore the safety and general health effects of BF, using
pre- and post-fasting observations to explore the strength and
duration of the fasting effects.
Study Size
The study was planned as an exploratory study to help
generate hypotheses for future studies. All p-values lower than
0.10 are regarded as potentially interesting and those below
0.05 as strongly interesting for future studies. The number
of the participants (n = 34) allows to detect all high-sized
and medium-sized effects of f ≥ 0.16, corresponding to a
Cohen’s d ≥ 0.32 (28) under the assumption of standard
parameters [alpha = 0.05, beta = 0.20 (power of 80%)] and a
higher correlation between measures of 0.7 (based on previous
in-house data).
Statistical Methods
As blood parameters are typically not normally distributed,
all analyses were conducted, using non-parametric tests. The
Friedman test, a counterpart to a one-factorial repeated measures
ANOVA, was used to compare the physiological parameters
across the four (three) clinical visits, while pairwise post-
hoc analyses were applied, using the Wilcoxon’s signed-rank
test. As usual, in exploratory studies, resulting p-values are
presented as such and not compared against any adjusted
alpha value.
Missing Data
Some physiological data were missing during the laboratory
failures and one subject not attending the last visit. The Little
test indicated that the missing data were completely at random
(“MCAR”) (29) and were replaced using multiple imputation




Thirty-four volunteers (15w, 19m, age: 41.09 ± 14.54 years)
practicing BF and living in or near Berlin participated in
the visits and tests of physiological parameters (group “PP”).
They had a mean BMI of 25.74 ± 5.13 kg/m², corresponding
well to the average BMI of 26 kg/m² in Germany (30).
Further sociodemographic data and baseline characteristics
of these participants are shown in Tables 1, 2, respectively.
Confidence intervals of the baseline laboratory parameters are
clinically unremarkable.
Of these 34 volunteers, 17 subjects (the “CB” subgroup)
donated additional blood samples for chronobiological
measurements. One participant was not able to attend the
last follow-up visit in person. While part of the visit could be
conducted via telephone (questionnaires), no physiological
samples could be obtained. These, as well as missing laboratory
data from some subjects for some visits due to a laboratory
failure, were filled in by multiple imputations (see Methods).
Outcomes
Primary Outcome: Hydration Markers
Plasma osmolality changed during fasting [χ²(3) = 19.61, P <
0.001]. It decreased from V0 to V1 and increased to baseline
(V0) or even higher levels from V1 to V2, returning to baseline
levels by V3 (Table 3, Figure 2A). However, all these changes
were within the physiological range.
Osmolality of the 24-hour urine (Figure 2B) changed
similarly [χ²(3) = 13.91, P < 0.001], with a decrease from V0 to
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TABLE 1 | Sociodemographic characteristics of the participants in the laboratory measurements.
Option 1 Option 2 Option 3 Option 4 Option 5
n Answer n (%) Answer n (%) Answer n (%) Answer n (%) Answer n (%)
Gender 34 Female 15 (44.1) Male 19 (55.9)
Graduation 33 A-level 10 (30.3) University 22 (66.7) Other 1 (3)
Gross income per
year [kEUR]
33 <20 18 (54.5) 20–40 4 (12.1) 40–60 5 (15.2) 60–80 2 (6.1) >80 4 (12.1)
Job 33 Self-Employed 7 (21.2) Employee 11 (33.3) Worker 2 (6.1) Student 10 (30.3) Other 3 (9.1)
TABLE 2 | Characteristics of participants at baseline (V0).
Original data Multiply imputed data
N Mean ± SD Median (IQR) 95% CI N Mean ± SD Median (IQR) 95% CI
Age 34 41.09 ± 14.54 39.5 (29) 36.02; 46.16
Hight, cm 34 173.49 ± 9.12 175.5 (15.1) 170.31; 176.67
Weight, kg 34 77.97 ± 19.19 75.3 (19.4) 71.28; 84.67
BMI, kg/m2 34 25.74 ± 5.13 24.52 (6.36) 23.95; 27.53
WHRa 34 0.90 ± 0.091 0.90 (0.13) 0.87; 0.93
Blood pressure sysb, mmHg 33 123.94 ± 18.32 120 (25) 117.44; 130.43 34 124.25 ± 18.13 120 (25) 117.93; 130.58
Blood pressure diac, mmHg 33 79.09 ± 10.71 80 (10) 79.09; 82.89 34 79.4 ± 10.70 80 (10) 75.66; 83.13
ß-Hydroxybutyrate, mmol/l 32 0.17 ± 0.19 0.15 (0.3) 0.10; 0.24 34 0.18 ± 0.20 0.18 (0.3) 0.11; 0.25
Glucose, mg/dl 33 83.48 ± 8.16 84 (13) 80.59; 86.38 34 83.07 ± 8.4 84 (13) 80.1; 86
HbA1c, mmol/mol Hb 34 33.78 ± 3.80 33.3 (4.9) 32.45; 35.10
Fructosamine, µmol/l 34 239.56 ± 20.49 243.5 (24) 232.41; 246.71
Body fat, kg 34 22.968 ± 10.81 19.1 (14.3) 19.20; 26.74
Body water, l 34 39.84 ± 9.56 38.7 (13.5) 36.51; 43.18
Body cell mass, kg 34 28.83 ± 7.89 29.8 (10.25) 26.08; 31.59
Resting metabolic rate, kcal 34 1,655.94 ± 323.87 1,626 (447) 1,542.94; 1,768.95
Haematocrit, l/l 34 0.412 ± 0.033 0.42 (0.04) 0.40; 0.42
Creatinine, mg/dl 33 0.79 ± 0.13 0.77 (0.21) 0.74; 0.83 34 0.79 ± 0.12 0.77 (0.21) 0.74; 0.83
Cystatin C, mg/l 33 0.911 ± 0.132 0.87 (0.18) 0.86; 0.96 34 0.92 ± 0.13 0.88 (0.2) 0.87; 0.96
GFR (CKD-EPI) 33 89.94 ± 3.58 91 (0) 88.67; 91.21 34 89.89 ± 3.53 91 (0) 88.66; 91.53
HDL, mg/dl 33 59.58 ± 15.68 58 (25) 54.02; 65.13 34 59.61 ± 14.44 58.5 (25) 54.22; 65.00
LDL, mg/dl 33 117.24 ± 27.90 119 (44) 107.35; 127.13 34 117.49 ± 27.51 119 (43) 107.89; 127.09
Sodium (plasma), mmol/l 33 141.33 ± 1.74 141 (32) 140.71; 141.95 34 141.81 ± 1.89 141 (32) 140.81; 142.13
Potassium (plasma), mmol/l 33 4.00 ± 0.29 4 (0.4) 3.90; 4.11 34 3.99 ± 0.31 4 (0.4) 3.88; 4.09
Sodium (bga), mmol/l 31 142.06 ± 1.57 142 (32) 141.49; 142.64 34 144.79 ± 20.03 142 (32) 137.8; 151.78
Potassium (bga), mmol/l 31 3.95 ± 0.23 4 (0.3) 3.86; 4.03 34 3.94 ± 2.08 4 (0.3) 3.22; 4.67
Osmolality plasma, mosmol/kg 33 289.76 ± 4 290 (5) 288.34; 291.18 34 289.61 ± 4.03 289.5 (4) 288.21; 291.02
Osmolality urine 24 h, mosmol/kg 33 471.36 ± 158.36 449 (235) 415.21; 527.52 34 532.16 ± 387.26 454 (257) 397.03; 667.28
Osmolality urine 12-h (6 a.m.−6 p.m.), mosm/kg 31 411 ± 161.98 389 (156) 351.59; 470.41 34 429.88 ± 206.54 399.5 (177) 357.82; 501.94
Osmolality urine 12-h (6 p.m.−6 a.m.), mosm/kg 33 562.73 ± 219.63 550 (347) 484.85; 640.60 34 566.33 ± 217.29 560 (336) 490.51; 642.14
aWHR, waist-to-hip ratio; bsys, systolic; cdia, diastolic.
V1 and a subsequent increase fromV1 toV2 to baseline levels. In-
depth analysis of the samples, however, revealed that this initial
decrease was mainly due to a distinct decrease in nocturnal urine
osmolality (sampled from 6 p.m. to 6 a.m.), whereas changes
in diurnal urine were less marked. Overall, these changes were
largely within the physiological range and, therefore, clinically
not relevant.
Kidney Values and Electrolytes
The glomerular filtration rate, as estimated by the equation of the
Chronic Kidney Disease Epidemiology Collaboration (GFR via
CKD-EPI), creatinine, and cystatin C did not change relevantly
during fasting (GFR: P = 0.584, creatinine: p = 0.060, and
cystatin C: p = 0.073). Creatinine showed a tendency to increase
slightly during fasting (V0–V1: 0.03± 0.09 mg/dl) and remained












































TABLE 3 | Anthropometric, blood, and urine parameters before, during, and after 19 days of Bahá’í fasting (BF).
Reference
range
V0 V1 V2 V3 Friedmann
main analysis
V1 vs. V0 V1 vs. V2 V2 vs. V0 V3 vs. V0 V1 vs. V3 V2 vs. V3
χ



























30.526 <0.001 0.892 1.000 −2.771 0.034 1.879 0.362 4.086 <0.001 −4.978 <0.001 −2.207 0.164








31.83 <0.001 4.36 <0.001 2.248 0.025 3.359 0.001 3.915 <0.001 0.53 0.596 1.103 0.27






















23.01 <0.001 4.496 <0.001 3.411 0.001 1.958 0.05 2.043 0.041 1.983 0.047 0.128 0.898
SBP, mmHg 120 (25) 120 (21) 115 (20) 120 (20) 12.229 0.007 1.503 0.797 −1.409 0.953 2.912 0.022 0.094 1.000 −1.409 0.953 −2.818 0.029




















43.45 <0.001 4.59 <0.001 4.915 <0.001 0.658 0.51 1.325 0.185 4.958 <0.001 0.932 0.351
HbA1c,
mmol/mol Hb











253 (32) 248 (22) 248 (17) 32.056 <0.001 5.401 <0.001 −2.630 0.051 2.771 0.034 4.039 <0.001 −1.362 1.000 −1.268 1.000
3-OH-B,
mmol/l
0.18 (0.3) 0.15 (0.3) 0.1 (0.2) 0 (0.2) 5.000 0.172
HDL, mg/dl >45 58.5 (25) 58.5 (19) 58 (23) 56 (17) 10.495 0.015 0.094 1.000 −0.047 1.000 0.141 1.000 2.489 0.077 −2.583 0.059 −2.630 0.051
LDL, mg/dl <130 119 (43) 115.5
(47)





















91 (0) 91 (0) 91 (1) 91 (36) 1.943 0.584
pNa+, mmol/l 136–145 141 (36) 142 (36) 142 (36) 141 (3) 3.884 0.274
pK+, mmol/l 3.4–4.5 4.0 (0.4) 3.8 (0.4) 4.1 (0.3) 4.0 (0.4) 16.111 0.001 1.315 1.000 −3.851 0.001 2.536 0.067 0.282 1.000 −1.597 0.662 −2.254 0.145
cNa+, mmol/l 136–145 142 (36) 142 (36) 141.5 (3) 141 (3) 6.683 0.083









































































































































































































































































































































































































































































































































































































































































































































































































































































































































FIGURE 2 | Changes in parameters of hydration, i.e., plasma osmolality (A)
and urine osmolality in 24-h, 12-h from 6a.m.−6 p.m. and 12-h from 6
p.m.−6 a.m. samples (B). Changes relative to V0-values. Line graphs and
error bars represent means and 95%-confidence intervals accordingly.
on this level after fasting when compared with baseline (V0–V2:
0.04± 0.08 mg/dl).
Sodium and potassium were measured in the plasma and
by blood gas analysis (BGA). Sodium measures did not change
relevantly, neither in plasma nor in the BGA. Potassium showed
a slight decrease in both plasma [χ²(3) = 16.111, p = 0.001] and
BGAmeasurements [χ²(3)= 10.867, p= 0.012]. Post-hoc testing
shows that this result is mainly based on the increase between V1
and V2 to a possibly over-compensational level at V2 for both
laboratory values.
Anthropometry
Body weight [χ²(3) = 18.027, p < 0.001], BMI [χ²(3) = 18,027,
p < 0.001], WHR [χ²(3) = 30.526, p < 0.001], body fat
[χ²(3)= 30.154, p < 0.001], body cell mass [χ²(3)= 13.823, p=
0.006], and the resting metabolic rate [χ²(3)= 21.931, p< 0.001]
show marked effects during fasting (Figure 3). Post-hoc analyses
revealed that this was mainly due to a decrease between V0 and
V1, sometimes extending to V2, rebounding thereafter again to
baseline levels until V3.
Glucose Metabolism
Marked changes were seen in plasma glucose [χ²(3) = 43.135,
P < 0.001], HbA1c [χ²(3)= 48.921, P< 0.001] and fructosamine
[χ²(3) = 32.056, P < 0.001]. During BF, plasma glucose was
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FIGURE 3 | Changes in metabolic parameters over the study period (A: BMI,
B: body fat mass, C: resting metabolic rate, D: glucose, and E: HbA1c).
Changes relative to V0-values. Line graphs and error bars represent means
and 95%-confidence intervals accordingly.
FIGURE 4 | Bahá’í fasting advanced the circadian phase in particular of late
chronotypes. (A) The circadian phase of 16 study participants was assessed,
using the blood monocyte-based BodyTime assay (26) before (V0), during
(V1), and 3 weeks after BF (V2). The circadian phase corresponds to the
BodyTime-predicted DLMO, which usually occurs about 2 hours before
habitual bedtime. (B) The extent of advancing the circadian phase during BF
correlated with chronotype (i.e., the circadian phase before BF).
considerably lower compared with visits before and after the fast.
Interestingly, HbA1c was decreased with a temporal delay to the
fast, with a smaller decrease between V0 and V1, reaching the
minimum only at V2. Here, even values at V3 were lower when
compared with baseline values.
Similarly, fructosamine was elevated during and after the fast
(V1, V2, and V3 vs. V0), indicating only slow recovery.
Chronobiology
The circadian phase (chronotype) of a subject, given by the
predicted dim-light melatonin onset (DLMO) assessed, using the
blood monocyte-based assay BodyTime (26), varied markedly
between the days of investigation [χ²(2) = 13.5, P = 0.001].
Chronotype during fasting (V1) was notably earlier than in V0
but returned to pre-fasting levels within the next 3 weeks (V2).
The extent of advancing the circadian phase correlated distinctly
with the initial chronotype, i.e., late chronotypes advanced more
than early chronotypes (slope = 0.34, P = 0.012, r = 0.61,
Figure 4). No correlations with other clinical outcomes were
found after adjustment.
Sex Effects
Repeated-measures ANOVA was used to examine the changes
over time in the interaction between sex and visits for BMI,
body fat mass, resting metabolic rate, glucose, HbA1c, plasma,
and urine osmolality (including 24-hour, diurnal and nocturnal
measurements), as well as for the chronobiological data. In this
explorative analysis, we could not detect any relevant differences.
DISCUSSION
This study aimed to generate hypotheses about the health
effects and safety of religiously motivated diurnal IDF. Particular
emphasis was placed on changes of hydration status, as
this aspect is the least scientifically explored until now.
Our results showed that hydration status varied slightly
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between fasting and non-fasting times in this study sample.
Although the mean changes in osmolality were within the
physiological range, it could, on scrutiny, be observed that
some dynamics seem to be present during nighttime, while
diurnal samples remain almost unchanged compared with non-
fasting samples.
In summary, our data indicate the safety of BF regarding
hydration and renal function. Even a slight diluting effect on
urine and plasma was observed. Despite a lower restingmetabolic
rate, the anthropometric indices, as well as glucose metabolism,
seemed to profit from BF, without a rebound being witnessed
even 3months later. The phase of circadian rhythms was changed
during BF, an effect being caused either by fasting itself or by
concomitant behavioral changes.
To our knowledge, this study is the first worldwide to assess
physiological and psychological changes during the religious
fast of the Bahá’ís. Different methodological approaches were
chosen to unravel cross-links between physiological parameters
and religious experience and objective and subjective dimensions
of this specific fast. This approach was confirmed even in
interpreting the laboratory data on the main study focus,
which was the hydration status. We showed that, during
BF, hydration parameters remained within physiological limits
or even indicated a dilution. Both serum and 24-hour-urine
osmolality dropped. In the qualitative interviews, some subjects
explained they would more consciously drink in the mornings
before sunrise (own data, publication pending), which could
explain part of the effect. But, as serum osmolality during BF was
measured in the afternoon, there might be more effects leading to
the slight dilution observed in most subjects. One of these could
be activation of the renin–angiotensin–aldosterone system. The
RAAS preserves body water resources by retaining sodium and
eliminating potassium. According to our data, the latter actually
decreased during BF, a finding which is in line with those in
Ramadan fasting (31, 32). This would also suit the slight increase
in osmolality in the afternoon spot urine samples. In prolonged
DF, an increase in RAAS activity has been described (20), as well
as an increase in serum osmolality only after 24-hour of DF, while
urine volume decreased (15). Our data showed a decrease in
both serum and urine osmolality in the 12- and 24-hour samples,
while total body water remained unchanged in the bioimpedance
analysis. Our findings suggest that, in the population studied, no
relevant dehydration occurred during IDF.
Comparing the outcomes of BF on body weight and the
metabolic rate with the results from the studies on Ramadan
fasting, we see a diverse picture in Ramadan fasting. Some studies
report a weight loss, others no change and even others a weight
gain during Ramadan fasting (33). Also, it seems that mostly
overweight people lose weight in Ramadan, while those with
normal weight do not show as much effect (12). As not enough
overweight individuals with a BMI ≥ 25 kg/m² were included,
this study cannot confirm a similar tendency in BF. A first data
analysis of our sub-study at the ECRC indicated an increased
adipose tissue lipid mobilization (publication pending). Thus, it
could be postulated that BF triggers lipid metabolism, leading to
a loss of body fat mass and body weight despite a reduction of the
resting metabolic rate.
Furthermore, the observed weight loss and the drop of
the resting metabolic rate, alongside the measurement of the
activity of the clock genes, show that cyclical changes in
energy metabolism influence nutrient utilization and that short-
term changes in meal frequency and timing have an effect on
chronobiology and energy balance. This is in line with the
findings on Ramadan fasting (33).
Previous studies showed that intermittent fasting can affect
sleep–wake patterns as well as circadian rhythms in animals and
humans. Popular readouts for circadian rhythmicity are repeated
measures of body temperature and melatonin levels as well as
subjective assessment of chronotype, using questionnaires. Here,
a recently developed BodyTime assay was used, in which only
one blood sample is needed to objectively assess the phase
of the circadian clock of an individual (26). Although the
BodyTime assay has not been validated in individuals under
specific fasting dietary regimens, it is important to note that,
in the study, in which we identified the biomarkers (26),
the subjects received hourly isocaloric snacks, whereas, in the
subsequent validation study, the participants were free to choose
the dietary regimen. At least, when comparing these largely
different dietary regimens, we found no difference in accuracy
in the circadian phase assessment. The results showed that BF
markedly advanced the circadian phase of fasting individuals by
more than 1 hour, which is reversed to normal levels 3 weeks
after fasting (Figure 4A). In animals, restricting food intake
to a few hours within their inactive phase substantially alters
circadian rhythms in peripheral tissues, while the master clock
in the hypothalamic suprachiasmatic nucleus remains largely
unaffected [for a review, see Manoogian and Panda (34)]. Studies
investigating how Ramadan fasting affects circadian rhythms
revealed conflicting results, since they often cannot discriminate
direct effects of fasting on the circadian system from indirect
effects of lifestyle changes [for a review, see Qasrawi et al. (35)].
However, it remains unclear whether BF alters the circadian
system per se or whether the observed phase advance of circadian
rhythms is rather due to altered sleeping times and thus altered
light exposure, which would phase shift circadian rhythms. A
limitation of our study is that we recorded neither light levels
nor sleeping time, which would have probably been helpful to
discriminate between these hypotheses. However, the fact that we
observed larger phase advances for later chronotypes (Figure 4B)
supports the second hypothesis, since the participants reported
eating and drinking before sunrise (own data, publication
pending), which requires relatively earlier wake-up times for late
types during BF compared with early types.
A possible bias of the study may originate from the fact that
rather healthy, highly educated volunteers participated in this
study. This sociodemographic distribution reflects findings from
another sample of Bahá’ís in Germany (21). To counteract these
biases and to track intraindividual changes during BF, this study
was designed as a longitudinal study with a pretest and a longer
follow-up than most of the Ramadan studies. As, in Germany,
the Bahá’í religion only has ∼6,000 followers in more than 100
localities (21), it was a challenge to get an adequate sample
size. Future confirmatory studies should be conducted in areas
with more Bahá’ís to allow higher participant numbers. Timing
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of samplings was yet another challenge. During BF, fasting
measurements were not possible in the mornings, as breakfast
was taken at dawn. Changes seen in physiological parameters
during BF may thus include time-of-day effects. To meet this
challenge, we included longer-term parameters, for example, 24
h-urine samples for osmolality or HbA1c for serum glucose,
as well as follow-up measurements. These show longer-lasting
changes, so we can exclude these were only due to time-of-
day effects.
Studies with higher participant numbers are needed to
validate the hypothesis of urine dilution and weight loss
during BF, as well as the improvement of glucose and fat
metabolism. Future studies should also focus on exploring
the physiological background of these clinical changes and
their potential impact on long-term health. It should also be
considered to study BF in different cultural contexts, as Bahá’ís
fast all over the world. Culturally different approaches to fasting
as well as the meal composition could influence the outcomes
under discussion.
In summary, this study showed that Bahá’í fasting, although
being shorter than other intermittent fasting regimes (5), might
have a notable impact on fat and glucose metabolism. Refraining
from drinking as well as chronobiological considerations might
be crucial in this metabolic shift and should be studied further,
especially as this study has not found critical effects on hydration
or renal parameters in this kind of intermittent dry fasting.
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